In our study, discontinuation was driven by a heterogeneous set of factors, including gastrointestinal adverse effects, treatment cost, pregnancy planning, and patient-perceived sufficiency of weight loss
As interest in taking glucagon-like peptide-1 receptor agonist (GLP-1 agonist) medications, such as Zepbound and Wegovy, for weight loss, research continues to examine potential new side effects of these types of drugs
Application of inorganic selenium to reduce accumulation and toxicity of heavy metals (metalloids) in plants: the main mechanisms, concerns, and risks
Some patients find it helpful to track meals or keep a food diary to ensure they are getting enough nutrients while adjusting to the medication
In addition to their anti-hyperglycaemic effects, these agents have been associated with CV protection in two large CV outcome trials [8, 9]